A community for China's biotech and pharmaceutical industries.

The biotech and pharmaceutical industries are taking priority in China. Recent changes to safety regulations and a general reorganization have increased BioChina’s productivity and influence in the life sciences. With a large scientific community, BioChina has appealed to foreign biotech companies, which now have a strong presence within the country and in the global market. China’s strong economy and dedication to the life sciences is expected to contribute to a thriving biotech industry now and in the future.


Hotbed News
Chinese Court Hits GlaxoSmithKline (GSK) With $492M Bribery Fine Monday, September 22, 2014
Week In Review: GlaxoSmithKline (GSK) Ends China Bribery Investigation By Paying $489 Million Fine Monday, September 22, 2014
Sedentary Lifestyle Linked To Depression, Qingdao University Medical College Study Monday, September 22, 2014
GlaxoSmithKline (GSK)'s Hefty Fine Signals No Immunity For Multinationals Monday, September 22, 2014
Biotech Layoffs Often Go Hand-In-Hand With CEO Pay Raises Monday, September 22, 2014
Biostar Pharmaceuticals, Inc. (BSPM) Files A PRC Patent Application For Oleanolic Acid Injection, Its New Drug Product For Hepatitis B And Liver Cancer Thursday, September 18, 2014
Milestone Scientific (MS) Starts Painless Botox Injection JV In China Wednesday, September 17, 2014
3SBio Inc. (SSRX) Obtains Exclusive Licenses To Develop And Market Jenkem's PEG-Irinotecan In China Wednesday, September 17, 2014
BeiGene Co.,Ltd Receives Clinical Milestone Payment For Development Of BGB-290 Monday, September 15, 2014
Extraordinary: 24 Year Old Woman Found To Have No Cerebellum In Her Brain Monday, September 15, 2014

Hotbed Directory